- Home
- KLRS vs GWH Comparison
KLRS vs GWH Comparison
Compare KLRS & GWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KLRS | GWH |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 37.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KLRS | GWH |
|---|---|---|
| Price | $9.50 | $1.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $20.67 | $2.67 |
| AVG Volume (30 Days) | 84.4K | ★ 468.7K |
| Earning Date | 02-24-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,021,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $68.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.14 | $0.76 |
| 52 Week High | $12.90 | $13.87 |
Technical Indicators
Market Signals| Indicator | KLRS | GWH |
|---|---|---|
| Relative Strength Index (RSI) | 55.69 | 37.42 |
| Support Level | $9.55 | $1.62 |
| Resistance Level | $10.47 | $1.96 |
| Average True Range (ATR) | 0.83 | 0.13 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 56.03 | 13.24 |
Price Performance
Historical ComparisonAbout KLRS Kalaris Therapeutics Inc.
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About GWH ESS Tech Inc.
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.